Mouse Anti-LRP1B Recombinant Antibody (VS3-FY2791) (CAT#: VS3-FY2791)

• Host Species
• Mouse

• Type
• Mouse IgG

• Specificity
• Human and Mouse LRP1B

• Species Reactivity
• Human, Mouse

• Applications
• Western Blot

• Conjugate
• Unconjugated, FITC

• MW
• The molecular weight of the target protein is approximately 515.5 kDa.

• Related Disease
• Thyroid Cancer and Lung Cancer

• Clonality
• Monoclonal Antibody

• Format
• Liquid

• Concentration
• Please refer to the vial label for the specific concentration.

• Storage
• Centrifuge briefly prior to opening vial. Store at +4°C for short term (1-2 weeks). Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.

• Application Notes
• Western Blot: 1/500-1/2000

• Alternative Names
• LRP-1B; LRPDIT; LRP-DIT

• Gene ID
• 53353

• UniProt ID
• Q9NZR2

• Sequence Similarities
• Belongs to the LDLR family.

• Cellular Localization
• Membrane

• Post Translation Modifications
• Glycosylation at Asn134, Asn190, Asn220, Asn313, Asn360, Asn443, Asn725, Asn758, Asn829, Asn883, Asn919, Asn1041, Asn1089, Asn1145, Asn1209, Asn1298, Asn1502, Asn1549, Asn1636, Asn1754, Asn1816, Asn1921, Asn1983, Asn2105, Asn2458, Asn2488, Asn2507, Asn2549, Asn2626, Asn2647, Asn2802, Asn2892, Asn3034, Asn3066, Asn3076, Asn3164, Asn3310, Asn3316, Asn3682, Asn3877, Asn3894, Asn3906, Asn4017, Asn4204, Asn4381, and Asn4420 (NX_Q9NZR2 [NX_Q9NZR2-1])
  Modification sites at PhosphoSitePlus (Q9NZR2)
  Glycosylation from GlyConnect LRP1B_HUMAN (1466)
  Glycosylation from GlyGen (Q9NZR2) 48 sites, 4 N-linked glycans (1 site), 2 O-linked glycans (2 sites)

• Protein Refseq
• XP_016859831.1; XP_047300727.1; XP_054198547.1; XP_054198548.1

• Function
• Potential cell surface proteins that bind and internalize ligands in the process of receptor-mediated endocytosis.

Secondary Antibody

• 2ND-040CQ
• Goat Anti-Mouse IgG (H&L) Antibody

Isotype Control

• MRO-A1591-YJ
• Mouse IgG Isotype control, Polyclonal

Select a product category from the dropdown menu below to view related products.